Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KIRK CAMPBELL

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1184761389
CMS profile
281204
Location
NEW YORK, NY

General Payments · PY2018–2024

$86,306.49

  • Reported across 83 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$45,670.12

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $5,870.86 7
PY2019 $4,117.68 12
PY2020 $11,086.01 11
PY2021 $6,081.89 6
PY2022 $5,644.23 6
PY2023 $7,835.70 6
PY2024 $45,670.12 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $670.00 10/30/2024 Consulting Fee Undisputed 01/23/2026 1093958724 CMS
AstraZeneca UK Limited $3,185.00 04/10/2024 Consulting Fee Undisputed 01/23/2026 1094048635 CMS
AstraZeneca UK Limited $46.53 10/23/2024 Food and Beverage Undisputed 01/23/2026 1093944017 CMS
CALLIDITAS THERAPEUTICS US INC. $11.73 05/16/2024 Food and Beverage Undisputed 01/23/2026 1141515257 CMS
CALLIDITAS THERAPEUTICS US INC. $1,197.49 09/27/2024 Travel and Lodging Undisputed 01/23/2026 1141523367 CMS
CALLIDITAS THERAPEUTICS US INC. $360.00 09/27/2024 Food and Beverage Undisputed 01/23/2026 1141523369 CMS
CALLIDITAS THERAPEUTICS US INC. $9,500.00 10/01/2024 Consulting Fee Undisputed 01/23/2026 1141523717 CMS
CALLIDITAS THERAPEUTICS US INC. $118.34 10/01/2024 Travel and Lodging Undisputed 01/23/2026 1141523719 CMS
CALLIDITAS THERAPEUTICS US INC. $157.24 10/23/2024 Food and Beverage Undisputed 01/23/2026 1141525302 CMS
CALLIDITAS THERAPEUTICS US INC. $56.60 12/07/2024 Food and Beverage Undisputed 01/23/2026 1141528865 CMS
CALLIDITAS THERAPEUTICS US INC. $91.28 12/08/2024 Food and Beverage Undisputed 01/23/2026 1141528963 CMS
Novartis Pharmaceuticals Corporation $5,350.00 02/09/2024 Consulting Fee Undisputed 01/23/2026 1086762775 CMS
Novartis Pharmaceuticals Corporation $209.97 02/09/2024 Food and Beverage Undisputed 01/23/2026 1086762825 CMS
Novartis Pharmaceuticals Corporation $141.57 02/09/2024 Travel and Lodging Undisputed 01/23/2026 1086762827 CMS
Novartis Pharmaceuticals Corporation $3,250.00 02/15/2024 Consulting Fee Undisputed 01/23/2026 1086762787 CMS
Novartis Pharmaceuticals Corporation $486.49 04/05/2024 Travel and Lodging Undisputed 01/23/2026 1086762831 CMS
Novartis Pharmaceuticals Corporation $2,600.00 10/11/2024 Consulting Fee Undisputed 01/23/2026 1086762813 CMS
Novartis Pharmaceuticals Corporation $88.75 10/25/2024 Food and Beverage Undisputed 01/23/2026 1086762845 CMS
Novartis Pharmaceuticals Corporation $45.01 10/25/2024 Food and Beverage Undisputed 01/23/2026 1086762847 CMS
Novartis Pharmaceuticals Corporation $139.99 11/07/2024 Food and Beverage Undisputed 01/23/2026 1086762853 CMS
Novartis Pharmaceuticals Corporation $55.48 11/07/2024 Food and Beverage Undisputed 01/23/2026 1086762855 CMS
Novartis Pharmaceuticals Corporation $123.67 12/07/2024 Food and Beverage Undisputed 01/23/2026 1086762849 CMS
Novo Nordisk Inc $40.55 02/01/2024 Food and Beverage Undisputed 01/23/2026 1097001528 CMS
Novo Nordisk Inc $68.04 02/01/2024 Food and Beverage Undisputed 01/23/2026 1097180475 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $3,467.50 11/14/2024 Consulting Fee Undisputed 01/23/2026 1118835817 CMS
SANOFI US SERVICES INC. $3,000.00 02/09/2024 Consulting Fee Undisputed 01/23/2026 1139999017 CMS
Travere Therapeutics, Inc. $145.59 09/07/2024 Food and Beverage Undisputed 01/23/2026 1149938962 CMS
Travere Therapeutics, Inc. $60.08 09/20/2024 Food and Beverage Undisputed 01/23/2026 1149938950 CMS
Travere Therapeutics, Inc. $378.57 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1149938966 CMS
Travere Therapeutics, Inc. $405.16 09/20/2024 Food and Beverage Undisputed 01/23/2026 1149938970 CMS
Travere Therapeutics, Inc. $476.52 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1149938974 CMS
Travere Therapeutics, Inc. $123.14 10/14/2024 Travel and Lodging Undisputed 01/23/2026 1149938958 CMS
Travere Therapeutics, Inc. $4,750.00 10/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1149938978 CMS
Travere Therapeutics, Inc. $4,750.00 10/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1149938982 CMS
Travere Therapeutics, Inc. $119.83 11/06/2024 Food and Beverage Undisputed 01/23/2026 1149938954 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.